SYSTEMIC REACTIVE AMYLOIDOSIS ASSOCIATED WITH CASTLEMANS-DISEASE - SERIAL CHANGES OF THE CONCENTRATIONS OF ACUTE-PHASE SERUM AMYLOID-A AND INTERLEUKIN-6 IN SERUM
Si. Ikeda et al., SYSTEMIC REACTIVE AMYLOIDOSIS ASSOCIATED WITH CASTLEMANS-DISEASE - SERIAL CHANGES OF THE CONCENTRATIONS OF ACUTE-PHASE SERUM AMYLOID-A AND INTERLEUKIN-6 IN SERUM, Journal of Clinical Pathology, 50(11), 1997, pp. 965-967
A case is reported of a 21 year old woman who suffered from Castleman'
s disease and systemic reactive amyloidosis. The serum concentrations
of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high
and amyloid protein was immunohistochemically identified as AA. After
surgical excision of a large retroperitoneal lymph node with the patho
logical findings of plasma cell type of Castleman's disease, both seru
m SAA and IL-6 declined, showing a similar pattern of reduction curves
. All clinical symptoms and laboratory abnormalities greatly improved.
The biochemical feature of Castleman's disease is abnormal production
of IL-6 and this cytokine continuously may stimulate the synthesis of
an amyloid precursor, SAA, causing systemic reactive (AA) amyloidosis
. This pathogenetic theory is strongly supported by the present study.